Financial Gravity Companies’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58 Buy
+4
New +$39 ﹤0.01% 947
2025
Q2
$29 Buy
+4
New +$32 ﹤0.01% 939
2024
Q4
$66 Hold
4
﹤0.01% 916
2024
Q3
$59 Buy
+4
New +$63 ﹤0.01% 634
2018
Q4
$1K Buy
+69
New +$1.03K ﹤0.01% 1158

Other funds holding NEO

Financial Gravity Companies's NEO Position: Q2 2026 in Review

Financial Gravity Companies opened a new position in NeoGenomics (NEO) in Q2 2026: 4 shares worth $58. The stake represents ﹤0.01% of the portfolio and ranks #947 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in NEO as recently as Q2 2025.

Financial Gravity Companies first reported a position in NEO in Q4 2018 and has held it in 5 quarters since. The position peaked at $1K in Q4 2018. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Financial Gravity Companies held 4 shares of NeoGenomics worth $58 as of Q2 2026.
  • NeoGenomics was a new Financial Gravity Companies position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2026, its #947 holding.
  • Financial Gravity Companies first reported a position in NeoGenomics in Q4 2018 and has held it in 5 quarters since.
  • Financial Gravity Companies's NeoGenomics position peaked at $1K in Q4 2018.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.